Type 2 Diabetes

Adding Dulaglutide, Liraglutide or Semaglutide (GLP-1 agonists) to existing treatment for type 2 diabetes has major cardiovascular benefits.  Exenatide* and Lixisenatide were neutral for providing cardiovascular benefits.

Can a diagnosis of resistant hypertension give clinicians a clue on what patients can expect for their future?

A recent study found important effects on dementia in African American patients with type 2 diabetes

Flu season is upon us; what does that mean for patients with type 2 diabetes?

Increased sugar in body tissues leads to more rapid growth of bacteria.

The use of GLP-1 receptor agonists in patients may prevent multiple risks.

Can depression affect the individual’s ability to perform any physical activity?

Could a timely diagnosis of diabetes improve management and health outcomes?

Unique directions for taking the pill may cause a compliance issue; it's not as simple as just taking a pill once a day.

This study discusses how restricting carbohydrates can reverse and prevent the metabolic syndrome.